Partner Headlines - CPHD

  1. Cepheid Announces Board of Directors Changes

    Benzinga

  2. Cepheid's Chlamydia and N. Gonorrhoeae Test Categorized ...

    Benzinga

  3. Medtech Stocks Moving As Conference Makes Waves

    Investors Business Daily

  4. Medtech Stocks Moving As Conference Makes Waves

    Investors Business Daily

  5. Cepheid Offers Update on Xpert Test Availability, Sees ...

    Benzinga

  6. UPDATE: Piper Jaffray Downgrades Cepheid to Neutral, ...

    Benzinga

  7. Oppenheimer Holdings Reiterates Outperform Rating, $43 ...

    Benzinga

  8. Canaccord Genuity Reiterates Buy Rating, $50 PT on Cepheid

    Benzinga

  9. Cantor Fitzgerald Reiterates Hold Rating, $38 PT on Cepheid

    Benzinga

  10. US Stock Futures Down Ahead Of Economic Data

    Benzinga

  11. Stocks To Watch For December 28, 2012

    Benzinga

  12. UPDATE: Cepheid Wins FDA Clearance for Xpert CT/NG

    Benzinga

  13. UPDATE: Bank of America Initiates Cepheid at Buy on ...

    Benzinga

  14. Look At That Base: If You Can't Name It, Don't Buy It

    Investors Business Daily

  15. UPDATE: Goldman Sachs Downgrades Cepheid to Neutral on ...

    Benzinga

  16. Benzinga's Top Downgrades

    Benzinga

  17. Benzinga's Top Upgrades

    Benzinga

  18. CEPHEID Reports Operating Results (10-Q)

    GuruFocus

  19. UPDATE: Cantor Fitzgerald Maintains Cepheid at Hold on ...

    Benzinga

  20. UPDATE: Canaccord Genuity Reiterates Cepheid at Buy with ...

    Benzinga

  21. Goldman Sachs Reiterates Buy Rating, $46 PT on Cepheid

    Benzinga

  22. UPDATE: ISI Group Reduces PT to $30.50 on Cepheid Post ...

    Benzinga

  23. Benzinga Mid-Afternoon Market Update

    Benzinga

  24. Stock Futures Point to Higher Open with Yahoo (YHOO) and ...

    At Market Intelligence Center

  25. Benzinga Mid-Day Market Update

    Benzinga

  26. Mid-Morning Market Update

    Benzinga

  27. UPDATE: ISI Group Reduces PT to $32.50 on Cepheid ...

    Benzinga

  28. Benzinga's Top Initiations

    Benzinga

  29. A Peek Into The Market Before The Trading Starts

    Benzinga

  30. UPDATE: JP Morgan Initiates Cepheid at Overweight on ...

    Benzinga

  31. Benzinga's Top Initiations

    Benzinga

  32. Technology Sector Wrap

    FOXBusiness

  33. Technology Sector Wrap

    FOXBusiness

  34. Technology Sector Wrap

    FOXBusiness

  35. Analyst Downgrades: Cepheid, Intuitive Surgical, and ...

    By SchaeffersResearch

  36. Cepheid Down 20% on Weak Guidance

    Benzinga

  37. CEPHEID (CPHD) CEO John L Bishop sells 40,201 Shares

    GuruFocus

  38. CEPHEID (CPHD) CEO John L Bishop sells 25,000 Shares

    GuruFocus

  39. CEPHEID (CPHD) EVP, CFO Andrew Miller sells 17,437 Shares

    GuruFocus

  40. A Peek Into The Market Before The Trading Starts

    Benzinga

  41. UPDATE: UBS Investment Research Upgrades Cepheid to Buy; ...

    Benzinga

  42. Benzinga's Top Downgrades With Color for May 14, 2012

    Benzinga

  43. UPDATE: GARP Research & Securities Downgrades Cepheid to ...

    Benzinga

  44. Cepheid Earnings Miss Estimates; Stock Plummets

    at IBD

  45. Cepheid Q1 Estimates Soft, But Outlook For Year Good

    at IBD

  46. Zoll Deal, Intutive Surgical Lift Medical Equipment

    at IBD

  47. Cepheid Stock Price Rises on Strong 2012 Sales Outlook

    at IBD

  48. CEPHEID Reports Operating Results (10-K)

    at GuruFocus

  49. CEPHEID (CPHD) EVP, CFO Andrew Miller sells 62,062 Shares

    at GuruFocus

  50. CEPHEID (CPHD) CEO John L Bishop sells 6,887 Shares

    at GuruFocus

  51. CEPHEID (CPHD) Executive VP, COO Humberto Reyes sells ...

    at GuruFocus

  52. Stocks Finish Week Split; Nasdaq, S&P 500 Higher

    at IBD

  53. Stocks Stay Mixed; Under Armour Clears 50-Day

    at IBD

  54. RBC Capital Upgrades Cepheid to Outperform

    at Benzinga

  55. UPDATE: Credit Suisse Initiates Outperform, $40 Target ...

    at Benzinga

  56. Analogic Earnings Preview: EPS Expected to Double

    at Benzinga
Marketplace
Trading Center